“The ball has become in the company’s court docket to conduct postmarket studies and surveillance on customer effect, and also to submit this facts to FDA per year,” said Dr. King. “If scientific proof indicates the net gains of these products no longer outweigh the pitfalls in the population level—or if the organization fails to perform